Innovative Technology for RNA Therapeutics
High-throughput screening technology for in vitro lead identification
Bioinformatics & Machine Learning
Software tools for optimal in silico design strategies
Proprietary RNA-targeting platform under development
La Jolla Labs leverages RNA biology, automation, cloud computing and machine learning to deliver transformative medicine to patients.
La Jolla Labs works with all RNA-targeting modalities including splicing gapmers, miRNA, antisense oligonucleotides and siRNA.
Fast and Effective Research and Screening Technology
Bioinformatics and ML
We are harnessing novel bioinformatics and machine learning techniques to build predictive oligonucleotide therapeutic tools and expand the therapeutic target space.
Our wet lab is leveraging robotics and automation to perform high-throughput screening of ASO therapeutics for potency and selectivity.
Our powerful fully integrated software platform efficiently filters out off-targets to quickly generate a series of potential oligonucleotide therapeutics.